ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,897,000 | +37.1% | 45,884 | 0.0% | 2.81% | +81.1% |
Q2 2021 | $5,758,000 | -7.5% | 45,884 | 0.0% | 1.55% | +8.3% |
Q1 2021 | $6,222,000 | +6.0% | 45,884 | 0.0% | 1.43% | -7.7% |
Q4 2020 | $5,870,000 | +13.7% | 45,884 | 0.0% | 1.55% | +38.0% |
Q3 2020 | $5,163,000 | +55.8% | 45,884 | +31.9% | 1.12% | +72.5% |
Q2 2020 | $3,314,000 | +6.0% | 34,784 | 0.0% | 0.65% | -10.8% |
Q1 2020 | $3,126,000 | -68.7% | 34,784 | -81.6% | 0.73% | -55.7% |
Q4 2019 | $10,000,000 | +34.2% | 188,602 | 0.0% | 1.65% | +4.6% |
Q3 2019 | $7,452,000 | -3.8% | 188,602 | 0.0% | 1.58% | -63.8% |
Q2 2019 | $7,748,000 | -11.8% | 188,602 | 0.0% | 4.36% | +9.9% |
Q1 2019 | $8,783,000 | -3.8% | 188,602 | -10.0% | 3.96% | -18.0% |
Q4 2018 | $9,128,000 | -27.6% | 209,602 | -4.8% | 4.84% | +3.7% |
Q3 2018 | $12,606,000 | +6.1% | 220,268 | -10.0% | 4.66% | +11.5% |
Q2 2018 | $11,876,000 | +24.1% | 244,756 | 0.0% | 4.18% | +31.4% |
Q1 2018 | $9,570,000 | -7.9% | 244,756 | 0.0% | 3.18% | -12.3% |
Q4 2017 | $10,387,000 | +13.7% | 244,756 | 0.0% | 3.63% | -2.0% |
Q3 2017 | $9,134,000 | +1633.2% | 244,756 | +1129.3% | 3.70% | +1538.1% |
Q1 2017 | $527,000 | +3.7% | 19,910 | 0.0% | 0.23% | -11.4% |
Q4 2016 | $508,000 | -69.4% | 19,910 | -59.2% | 0.26% | -77.5% |
Q2 2016 | $1,660,000 | -63.9% | 48,839 | -71.9% | 1.14% | -49.5% |
Q1 2016 | $4,594,000 | -31.5% | 174,089 | +26.6% | 2.25% | +0.0% |
Q4 2015 | $6,702,000 | +35.4% | 137,458 | -30.8% | 2.25% | +49.6% |
Q3 2015 | $4,948,000 | +402.8% | 198,717 | +539.0% | 1.50% | +335.4% |
Q2 2015 | $984,000 | – | 31,100 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |